PREVIEW
OF YOUR NEWS WIDGETHigh blood pressure news and high blood pressure widget
Friday, October 24, 2008 ( change date )
Addrenex Pharmaceuticals Initiates Phase 2 Trial On Its Novel Hypertension Drug, ADX415
Addrenex Pharmaceuticals announced that the U.S. Food and Drug Administration has approved its Investigational New Drug Application (IND) for ADX415, a novel hypertension drug. With the approval, Addrenex has launched a phase 2 clinical trial to study ADX415 as a targeted therapy for hypertension. The phase 2 trial is a multicenter, double-blind, placebo-controlled, dose-ranging study that will involve 80 patients.
Medicalnewstoday.com Friday, October 24, 2008Hydrogen Sulfide Key Player in Blood Pressure Regulation
Title: Hydrogen Sulfide Key Player in Blood Pressure RegulationCategory: health newscreated: 10/24/2008 2:00:00 amlast Editorial review: 10/24/2008
MedicineNet Friday, October 24, 2008Health Tip: Risk Factors for Heart Disease
Title: health Tip: Risk Factors for Heart DiseaseCategory: health newscreated: 10/24/2008 2:00:00 amlast Editorial review: 10/24/2008
MedicineNet Friday, October 24, 2008Exercise Improves Stroke Outcome
Title: Exercise Improves Stroke OutcomeCategory: health newscreated: 10/24/2008 2:00:00 amlast Editorial review: 10/24/2008
MedicineNet Friday, October 24, 2008
INSTALL YOUR WIDGET